Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients

Abstract

Addition of glimepiride to metformin in Type 2 diabetic patients inadequately controlled by metformin alone resulted in superior glycaemic control compared with glimepiride or metformin monotherapy.